Atlas Arteria Board Urges Investors to Reject IFM’s $4.75 Hostile Takeover Bid

Atlas Arteria board urges investors to reject IFM’s $4.75 hostile bid

The Independent Directors of Atlas Arteria have unanimously recommended securityholders reject IFM’s hostile takeover offer, describing it as “too low, opportunistic and highly conditional.” The offer values the toll road operator at $4.75 cash per stapled security (less any distributions paid), with a potential increase to $5.10 if IFM reaches 45% relevant interest. The offer price sits below Atlas Arteria’s closing price of $4.79 on 5 May 2026, the day before the announcement.

Chair Debbie Goodin stated the offer “materially undervalues Atlas Arteria” and is designed to accelerate IFM’s path to effective control without paying a fair premium to securityholders. To reject the offer, securityholders simply need to ignore all correspondence from IFM. Each Independent Director intends to reject the offer for their own (ASX: ALX) securities.

The board’s defence centres on valuation inadequacy, extensive conditionality, and timing opportunism. Atlas Arteria has lodged a Takeovers Panel application regarding structural deficiencies in the offer and disclosure within the Bidder’s Statement. A Target’s Statement, including an independent expert’s report, will be dispatched to securityholders at least 14 days before the offer closes.

Why the board says IFM’s offer undervalues Atlas Arteria

The Independent Directors argue the $4.75 offer represents a premium of less than 10% to the last closing price before the offer was announced. Even at the potential $5.10 price point, the premium would be only around 3% above the 12-month volume-weighted average price (VWAP) of $4.94 and less than 20% above the pre-offer closing price.

The board contrasts this with typical control transaction premiums for high-quality listed infrastructure assets, which substantially exceed the proposed levels. Atlas Arteria traded as high as $5.54 in the last 12 months and was trading above $5.10 as recently as November 2025. Critically, IFM itself acquired securities at $5.10 in November 2025 but now offers only $4.75 for control.

The board attributes current security price weakness to macro volatility unrelated to fundamental asset value. Recent factors include the Middle East conflict, foreign exchange movements, interest rate shifts, and increasing illiquidity stemming from IFM’s existing holding. The directors maintain these transient factors have created a divergence between market price and the fundamental value of the global toll road portfolio, which IFM is now seeking to exploit.

Extensive conditions create uncertainty for accepting securityholders

The offer contains 13 separate condition categories and more than 50 sub-conditions spanning over 10 pages. All conditions must be satisfied or waived for the offer to complete, giving IFM what the board describes as a “free option” to withdraw even if conditions are breached early in the process. IFM retains the right to decide whether to proceed or walk away towards the end of the offer period.

The Independent Directors have identified three conditions they believe are already incapable of being satisfied:

1. Condition 6 (Change of control): Requires Ontario Teachers’ Pension Plan (OTPP) to waive rights under the Chicago Skyway Shareholders Agreement for no consideration. The board considers it commercially unreasonable to expect OTPP to surrender valuable contractual rights without compensation.

2. Condition 11(d) (Capital expenditure): Will not be satisfied due to business-as-usual capital expenditure requirements across Atlas Arteria’s concession companies.

3. Condition 11(k): Will be triggered by normal intragroup capital distributions necessary for operational management.

The conduct of business conditions would constrain day-to-day operations and strategic initiatives throughout the offer period, potentially frustrating value-accretive opportunities. The no distributions condition would deprive securityholders of distributions previously flagged in company guidance. Regulatory approval conditions lack any statement from IFM explaining progress towards satisfaction.

Understanding hostile takeover conditions

Conditional takeover offers introduce execution risk for investors who choose to accept. When a bidder includes extensive conditions, they retain the flexibility to withdraw if market conditions deteriorate or better opportunities emerge. This creates a “free option” structure where the bidder can observe developments before committing capital.

Conditions requiring third-party waivers, such as OTPP’s contractual rights under the Chicago Skyway Shareholders Agreement, introduce uncertainty outside the bidder’s control. Third parties are under no obligation to waive valuable commercial rights to facilitate a transaction from which they receive no benefit. For accepting securityholders, this means locking up their securities without certainty that the transaction will complete or that the offer price will be paid. If conditions fail, securities may be returned months later, during which time investors have foregone alternative opportunities.

Chicago Skyway sale process adds complexity to timing

Atlas Arteria issued a Right of First Offer (ROFO) notice to OTPP for its Chicago Skyway interest on 22 April 2026, five days before IFM announced its hostile offer. The ROFO was unanimously approved by both boards, including IFM nominee directors, at a price in line with Atlas Arteria’s 2022 acquisition price for the asset. The ROFO notice was issued before the board had any knowledge of IFM’s impending bid.

Under the Chicago Skyway Shareholders Agreement, Atlas Arteria must issue a ROFO to OTPP before engaging with third parties regarding its ownership interest. If OTPP accepts, Atlas Arteria must sell to OTPP. If OTPP declines, Atlas Arteria intends to explore strategic alternatives for its Chicago Skyway interest, including a possible third-party sale.

The existence of the ROFO itself breaches one of IFM’s offer conditions, despite being issued before the offer was made. This highlights the restrictive nature of the conditions package.

IFM’s Bidder’s Statement emphasises the risk that OTPP could exercise a put option if there is a change of control at Atlas Arteria. Under this mechanism, if a third party acquires beneficial ownership in more than 50% of Atlas Arteria, OTPP has the option to sell its Chicago Skyway interest to Atlas Arteria at fair market value plus 7.5%. IFM has sought to characterise this as a material risk requiring an equity raising to fund.

However, IFM simultaneously requires OTPP to waive this contractual right as a condition of the offer. The board describes this as “a jarring inconsistency” in IFM’s position, highlighting the put option as a risk whilst demanding OTPP surrender the right that creates that risk.

Chair Debbie Goodin

“This hostile, highly conditional takeover offer from IFM is opportunistic and materially undervalues Atlas Arteria. The Offer is designed to accelerate IFM’s creep to effective control of Atlas Arteria without paying a fair premium to securityholders.”

The board has been exploring initiatives to address the put option that would not require an equity raising. These initiatives are being pursued in the context of current engagement with OTPP regarding the ROFO. IFM has provided no information to securityholders about its intentions if the put option were triggered whilst IFM controlled Atlas Arteria.

What happens next for Atlas Arteria investors

Atlas Arteria confirms distribution guidance of 40.0 cents per stapled security for 2026, subject to standard caveats including continued business performance, tax changes, foreign exchange movements, and future events. The board believes more than $5.10 may be available to securityholders in the next 12 months through multiple pathways.

IFM has maintained the ability to offer up to $5.10 per stapled security in the 12 months following the offer close, without adjusting that amount for any distributions Atlas Arteria makes to securityholders. This creates potential for securityholders to receive the higher price point plus distributions. Atlas Arteria continues to target future distributions of at least 40.0 cents per stapled security in addition to any special returns from corporate initiatives, including portfolio optimisation and asset recycling.

Atlas Arteria has lodged an application to the Takeovers Panel to address structural deficiencies in the offer and disclosure within the Bidder’s Statement. The Independent Directors sought to resolve these matters with IFM before the Bidder’s Statement dispatch but report that IFM refused to adequately address the concerns. In accordance with Takeovers Panel media canvassing policy, Atlas Arteria is limited in what it can disclose at this stage.

Key dates and actions for investors:

1. To REJECT: Simply ignore all correspondence from IFM
2. Target’s Statement: Will be dispatched at least 14 days before the offer closes, including an independent expert’s report
3. Distribution Guidance: 40.0 cents per stapled security for 2026 remains in place
4. Takeovers Panel Application: Lodged to address structural deficiencies and disclosure concerns

Each Independent Director intends to reject the offer for their own Atlas Arteria securities. The board remains focused on continuing to deliver on the strategy to optimise company value and create value for all securityholders, including through initiatives already underway before IFM’s hostile approach.

Want the Next Infrastructure Takeover in Your Inbox?

Join 20,000+ investors getting FREE breaking ASX news delivered within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at StockWire X to receive real-time alerts on takeover bids, board responses, and major corporate actions the moment they hit the market.